Therapy Fusion Limited 06321030 false 2022-08-01 2023-07-31 2023-07-31 The principal activity of the company is physiotherapy and teaching. Digita Accounts Production Advanced 6.30.9574.0 true 06321030 2022-08-01 2023-07-31 06321030 2023-07-31 06321030 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 06321030 core:Non-currentFinancialInstruments core:AfterOneYear 2023-07-31 06321030 bus:Micro-entities 2022-08-01 2023-07-31 06321030 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 06321030 bus:FullAccounts 2022-08-01 2023-07-31 06321030 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 06321030 bus:RegisteredOffice 2022-08-01 2023-07-31 06321030 bus:CompanySecretary1 2022-08-01 2023-07-31 06321030 bus:Director1 2022-08-01 2023-07-31 06321030 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 06321030 countries:EnglandWales 2022-08-01 2023-07-31 06321030 2021-08-01 2022-07-31 06321030 2022-07-31 06321030 core:CurrentFinancialInstruments core:WithinOneYear 2022-07-31 06321030 core:Non-currentFinancialInstruments core:AfterOneYear 2022-07-31 iso4217:GBP xbrli:pure

Registration number: 06321030

Therapy Fusion Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 July 2023

 

Therapy Fusion Limited

Company Information

Director

Michelle Watson

Company secretary

Christine Myra Marr

Registered office

Trinity House
Aintree Road
Stratford-upon-Avon
CV37 9FL

 

Therapy Fusion Limited

Director's Report for the Year Ended 31 July 2023

The director presents her report and the financial statements for the year ended 31 July 2023.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Director of the company

The director who held office during the year was as follows:

Michelle Watson

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 17 November 2023
 

.........................................
Michelle Watson
Director

 

Therapy Fusion Limited

(Registration number: 06321030)
Balance Sheet as at 31 July 2023

2023
£

2022
£

Fixed assets

34,360

41,485

Current assets

7,860

10,697

Prepayments and accrued income

661

180

Creditors: Amounts falling due within one year

(9,225)

(13,019)

Net current liabilities

(704)

(2,142)

Total assets less current liabilities

33,656

39,343

Creditors: Amounts falling due after more than one year

(18,345)

(20,625)

Accruals and deferred income

(4,790)

(4,631)

 

10,521

14,087

Capital and reserves

10,521

14,087

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Trinity House
Aintree Road
Stratford-upon-Avon
CV37 9FL
UK

These financial statements were authorised for issue by the director on 17 November 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

For the financial year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Therapy Fusion Limited

(Registration number: 06321030)
Balance Sheet as at 31 July 2023

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 17 November 2023
 

.........................................
Michelle Watson
Director